Opportunity ID: 292850

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-17-240
Funding Opportunity Title: Innovative Research in Cancer Nanotechnology (IRCN) (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 30, 2017
Last Updated Date:
Original Closing Date for Applications: May 21, 2020
Current Closing Date for Applications: May 21, 2020
Archive Date: Jun 26, 2020
Estimated Total Program Funding:
Award Ceiling: $450,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
State governments
City or township governments
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Special district governments
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is a component of a broader program that is the NCI Alliance for Nanotechnology in Cancer. IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. This scope includes research concerning the delivery of nanoparticles and/or nanodevices to desired and intended cancer targets in vivo and/or characterization of in vitro detection and diagnostic devices.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-17-240.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-D Use for due dates on or before January 24, 2018 PKG00231727 Oct 21, 2017 Jan 24, 2018 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00235940 Nov 08, 2017 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259035 Oct 21, 2017 May 21, 2020 View

Package 1

Mandatory forms

292850 RR_SF424_2_0-2.0.pdf

292850 PHS398_CoverPageSupplement_3_0-3.0.pdf

292850 RR_OtherProjectInfo_1_3-1.3.pdf

292850 PerformanceSite_2_0-2.0.pdf

292850 RR_KeyPersonExpanded_2_0-2.0.pdf

292850 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

292850 RR_Budget_1_3-1.3.pdf

292850 RR_SubawardBudget30_1_3-1.3.pdf

292850 PHS398_ModularBudget_1_2-1.2.pdf

292850 PHS_Inclusion_Enrollment_Report-1.0.pdf

292850 PHS_AssignmentRequestForm-1.0.pdf

Package 2

Mandatory forms

292850 RR_SF424_2_0-2.0.pdf

292850 PHS398_CoverPageSupplement_4_0-4.0.pdf

292850 RR_OtherProjectInfo_1_4-1.4.pdf

292850 PerformanceSite_2_0-2.0.pdf

292850 RR_KeyPersonExpanded_2_0-2.0.pdf

292850 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

292850 RR_Budget_1_4-1.4.pdf

292850 RR_SubawardBudget30_1_4-1.4.pdf

292850 PHS398_ModularBudget_1_2-1.2.pdf

292850 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 3

Mandatory forms

292850 RR_SF424_2_0-2.0.pdf

292850 PHS398_CoverPageSupplement_5_0-5.0.pdf

292850 RR_OtherProjectInfo_1_4-1.4.pdf

292850 PerformanceSite_2_0-2.0.pdf

292850 RR_KeyPersonExpanded_2_0-2.0.pdf

292850 PHS398_ResearchPlan_4_0-4.0.pdf

292850 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

292850 RR_Budget_1_4-1.4.pdf

292850 RR_SubawardBudget30_1_4-1.4.pdf

292850 PHS398_ModularBudget_1_2-1.2.pdf

292850 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T04:54:42-05:00

Share This Post, Choose Your Platform!

About the Author: